BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7948956)

  • 1. Rearrangement of the chicken lambda light chain locus: a silencer/antisilencer regulation.
    Ferradini L; Reynaud CA; Lauster R; Weill JC
    Semin Immunol; 1994 Jun; 6(3):165-73. PubMed ID: 7948956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer sequences located 3' of the mouse immunoglobulin lambda locus specify high-level expression of an immunoglobulin lambda gene in B cells of transgenic mice.
    Eccles S; Sarner N; Vidal M; Cox A; Grosveld F
    New Biol; 1990 Sep; 2(9):801-11. PubMed ID: 2126202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotype exclusion and transgene down-regulation in immunoglobulin-lambda transgenic mice.
    Neuberger MS; Caskey HM; Pettersson S; Williams GT; Surani MA
    Nature; 1989 Mar; 338(6213):350-2. PubMed ID: 2493585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chicken immunoglobulin lambda light chain gene is transcriptionally controlled by a modularly organized enhancer and an octamer-dependent silencer.
    Bulfone-Paus S; Reiners-Schramm L; Lauster R
    Nucleic Acids Res; 1995 Jun; 23(11):1997-2005. PubMed ID: 7596829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of Ig gene rearrangement by a 150-bp transcriptional silencer.
    Cocea L; Dahan A; Ferradini L; Reynaud CA; Weill JC
    Eur J Immunol; 1998 Sep; 28(9):2809-16. PubMed ID: 9754568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter, enhancer and silencer elements regulate rearrangement of an immunoglobulin transgene.
    Lauster R; Reynaud CA; MÃ¥rtensson IL; Peter A; Bucchini D; Jami J; Weill JC
    EMBO J; 1993 Dec; 12(12):4615-23. PubMed ID: 8223471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombination silencer that specifies heterochromatin positioning and ikaros association in the immunoglobulin kappa locus.
    Liu Z; Widlak P; Zou Y; Xiao F; Oh M; Li S; Chang MY; Shay JW; Garrard WT
    Immunity; 2006 Apr; 24(4):405-15. PubMed ID: 16618599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene conversion contributes to Ig light chain diversity in cattle.
    Parng CL; Hansal S; Goldsby RA; Osborne BA
    J Immunol; 1996 Dec; 157(12):5478-86. PubMed ID: 8955197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive junctional diversity in Ig light chain genes from early B cell progenitors of mu MT mice.
    Bentolila LA; Olson S; Marshall A; Rougeon F; Paige CJ; Doyen N; Wu GE
    J Immunol; 1999 Feb; 162(4):2123-8. PubMed ID: 9973486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa and lambda rearrangement occur simultaneously in transformed pre-B cells.
    Liu D; Jenab J; Rosenberg N
    J Immunol; 1997 Dec; 159(12):6061-9. PubMed ID: 9550405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic and selective constraints act on the establishment of V lambda J lambda junctions in the B cell repertoire.
    Boudinot P; Drapier AM; Cazenave PA; Sanchez P
    J Immunol; 1994 Mar; 152(5):2248-55. PubMed ID: 8133038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical map of the mouse lambda light chain and related loci.
    Gerdes T; Wabl M
    Immunogenetics; 2002 Apr; 54(1):62-5. PubMed ID: 11976793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models for antigen receptor gene rearrangement. I. Biased receptor editing in B cells: implications for allelic exclusion.
    Mehr R; Shannon M; Litwin S
    J Immunol; 1999 Aug; 163(4):1793-8. PubMed ID: 10438911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma heavy chain disease in man: independent structural abnormalities and reduced transcription of a functionally rearranged lambda L-chain gene result in the absence of L-chains.
    Teng MH; Rosen S; Gorny MK; Alexander A; Buxbaum J
    Blood Cells Mol Dis; 2000 Jun; 26(3):177-85. PubMed ID: 10950937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of putative cis-regulatory elements that control the transcriptional activity of the human Oct4 promoter.
    Yang HM; Do HJ; Oh JH; Kim JH; Choi SY; Cha KY; Chung HM; Kim JH
    J Cell Biochem; 2005 Nov; 96(4):821-30. PubMed ID: 16149048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
    Klotz EL; Storb U
    J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice: a tool for the study of tissue-specific gene expression.
    Jami J
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):7-11. PubMed ID: 3133635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells selected for apoptosis in the sheep ileal Peyer's patch have enhanced mutational diversity in the Ig V lambda light chain.
    Maybaum TA; Reynolds JD
    J Immunol; 1996 Aug; 157(4):1474-84. PubMed ID: 8759728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variegated transcriptional activation of the immunoglobulin kappa locus in pre-b cells contributes to the allelic exclusion of light-chain expression.
    Liang HE; Hsu LY; Cado D; Schlissel MS
    Cell; 2004 Jul; 118(1):19-29. PubMed ID: 15242641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
    Schlissel MS; Morrow T
    J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.